Send us Feedback

Abraxis BioScience (ABII)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ABII » Topics » (Unaudited, in thousands, except per share amounts)

This excerpt taken from the ABII 8-K filed May 15, 2008.

(Unaudited, in thousands, except per share amounts)

Adjusted net income and adjusted net income per share are defined as net income and net income per share, respectively, in each case excluding the impact of non-cash stock compensation expense, amortization of acquired intangible assets, and Phoenix pre-launch costs. We believe that our presentation of non-GAAP financial measures provides useful supplementary information to investors in understanding our underlying operating performance and facilitates additional analysis by investors. We also use non-GAAP financial measures internally for operating, budgeting and financial planning purposes. The non-GAAP financial measures are in addition to, and not a substitute for or superior to, measures of financial performance calculated in accordance with GAAP. Reconciliation of net income and net income per share to adjusted net income and adjusted net income per share for the three months ended March 31, 2008 and 2007 is below:

 

      Three Months Ended
March 31,		  
     2008    2007  

Net income (loss)

    $ 4,309    $ (5,671 )

Intangible amortization related to merger

      9,651      5,958  

Phoenix pre-launch costs

      2,929      —    

Stock compensation expense

      2,993      4,014  
               

Adjusted net income

    $ 19,882    $ 4,301  
               

Adjusted net income per diluted share

    $ 0.49    $ 0.11  
               

Weighted-average common shares outstanding diluted

      40,196      39,990  
               
      Adjusted Net Income
Per Share		  

Net income (loss) per share

    $ 0.11    $ (0.14 )

Intangible amortization related to merger

      0.24      0.15  

Phoenix pre-launch costs

      0.07      —    

Stock compensation expense

      0.07      0.10  
               

Adjusted net income per share

    $ 0.49    $ 0.11  
               

"(Unaudited, in thousands, except per share amounts)" elsewhere:

Anesiva (ANSV)
Diversa (DVSA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki